FMB Research

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
May 23, 2021	Arch Oncology	$105.0M Series C	Joe Biller, CFA, Eric Pham, Joy Ghosh	Adage Capital Management, Avego Healthcare Capital, Broadfin Holdings, Lightchain, Point72, John McKearn, Roche

Total Raised

N/A

Valuation

N/A